Source: Annual Congress 2005 - Pulmonary arterial hypertension diagnosis and therapy
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. A. Aldashev, B. K. Kojonazarov, M. M. Mirrakhimov, N. W. Morrell, M. R. Wilkins (Bishkek, Kyrgyzstan; London, United Kingdom). Pulmonary hemodynamics in highlanders with high altitude pulmonary hypertension in 1 year after finishing of sildenafil treatment. Eur Respir J 2005; 26: Suppl. 49, 1338

Member's Comments

No comment yet.

Related content which might interest you: Hemodynamic effects of sildenafil in pulmonary arterial hypertension (PAH) patients Source: Annual Congress 2005 - Treatment of pulmonary arterial hypertension Year: 2005 Haemodynamic evaluation of pulmonary hypertension Source: Eur Respir J 2002; 20: 1314-1331 Year: 2002 Bosentan combined with sildenafil prevents right ventricular hypoxia in pulmonary arterial hypertension Source: Annual Congress 2008 - Pathophysiology of pulmonary hypertension Year: 2008 Right and left ventricular function in lowlanders with COPD travelling to moderate altitude Source: International Congress 2015 – Pulmonary hypertension in lung disease Year: 2015 Pulmonary haemodynamics during exercise in patients with pulmonary arterial hypertension Source: Annual Congress 2005 - Exercise testing in pulmonary arterial hypertension Year: 2005 Amelioration of right ventricular morphology and systolic function in patients with severe group 3 pulmonary hypertension treated with pulmonary vasodilators Source: International Congress 2015 – Pulmonary hypertension in lung disease Year: 2015 Combining bosentan and sildenafil improves mitochondrial capacity and restores right ventricular contractility in established pulmonary hypertension Source: Annual Congress 2007 - Pathogenesis and novel therapeutic targets in pulmonary hypertension Year: 2007 Clinical significance of right ventricular diastolic dysfunction in pulmonary arterial hypertension Source: Annual Congress 2005 - News about pulmonary embolism Year: 2005 Right ventricular diastolic function in high altitude pulmonary hypertension Source: Eur Respir J 2002; 20: Suppl. 38, 99s Year: 2002 Cardiac function during exercise in pulmonary arterial hypertension Source: Annual Congress 2005 - Exercise in pulmonary hypertension Year: 2005 High-altitude disease Source: Respipedia Article Year: 2017 The association between resting and mild-to-moderate exercise pulmonary artery pressure Source: Eur Respir J 2012; 39: 313-318 Year: 2012 Effect of sitaxentan on haemodynamics and right ventricular hypertrophy in monocrotaline-induced pulmonary arterial hypertension (PAH) Source: Annual Congress 2008 - Pulmonary vascular biology Year: 2008 Vascular and right ventricular remodelling in chronic thromboembolic pulmonary hypertension Source: Eur Respir J 2013; 41: 224-232 Year: 2013 Haemodynamic responses to exercise in patients with COPD Source: Eur Respir J 2013; 41: 1031-1041 Year: 2013 The effects of beta-blocker therapy on heart rate, symptoms and exercise in pulmonary arterial hypertension Source: Annual Congress 2013 –Pulmonary circulation: clinical treatment Year: 2013 Deleterious effects of ß-blockers on exercise capacity and hemodynamics in portopulmonary hypertension Source: Annual Congress 2005 - Treatment of pulmonary arterial hypertension Year: 2005 Changes in exercise haemodynamics during treatment in pulmonary arterial hypertension Source: Eur Respir J 2008; 32: 393-398 Year: 2008 Haemodynamics during vasodilator test comparing urapidil and nicardipine to NO in pulmonary arterial hypertension Source: Annual Congress 2005 - Treatment of pulmonary arterial hypertension Year: 2005